eoadjuvant Chemotherapy with Oxaliplatin plus Fluorouracil l-Leucovorin or Oxaliplatin plus Capecitabin and MoAb for resectable colorectal liver metastases(CML) from tokai digestive cancer trials group
Phase 2
Recruiting
- Conditions
- Resectable Liver Metastases From Colorectal Cancer
- Registration Number
- JPRN-UMIN000003796
- Lead Sponsor
- Epidemiological and Clinical Research Information Network
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1,Serious myelosuppression 2.Serious infection 3,Large quantity of abdominal or pleural effusion 4,cardiovascular disease, complication 5,sensory alteration or paresthesia interfering with function 6,No brain or bone metastasis, active double cancer 7,No hypersensitivity for test drugs 8,Serious pulmonary disease 9,Liver cirrhosis 10,Multiple cancer patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression-free survival
- Secondary Outcome Measures
Name Time Method anti-tumor effect overall survival R0 resection rate